Sysmex Europe has launched its sample preparation system PS-10 for IVD use in the EMEA region. By automating the sample preparation work in clinical flow cytometry laboratories, the PS-10 helps establish workflows which are more efficient, relieving staff from manual work, easing their burden of documentation and assisting in the standardisation of clinical flow cytometry […]
Porvair Sciences Ultravap Mistral XT 150 blowdown evaporator is now able to operate at temperatures up to 80°C thereby significantly increasing the rate of evaporation of both organic solvents and aqueous solutions.
The EURORealTime SARS-CoV-2 from EUROIMMUN is now validated for use with saliva as sample material as an alternative to throat swabs. Collection of saliva specimens is easier and less distressing for patients than taking nasal or throat swabs, especially for children.
The EURORealTime SARS-CoV-2 from EUROIMMUN is now validated for use with saliva as sample material as an alternative to throat swabs. Collection of saliva specimens is easier and less distressing for patients than taking nasal or throat swabs, especially for children.
Nobelpharma has signed a license agreement for the use of ProBioGen’s AGE1.CR.pIX vaccine production platform to develop theirlead vaccine.
20/20 GeneSystems has launched its Clinical Lab Innovation Axcellerator (CLIAx), believed to be the first shared CLIA laboratory facility geared to helping diagnostic test innovators worldwide substantially reduce the time and cost of launching their tests in the U.S.
Pureos Bioventures, a venture capital fund dedicated to support private biotech companies developing novel therapies, has appointed several venture partners to its team. The firsttime fund has US$205 million under management and has invested in 11 private biotech companies so far. In addition, Pureos is a partner at BaseLaunch, an incubator of biotech startups in […]
Uniqsis reports how researchers at the School of Chemistry, University of Bristol (UK) have successfully prepared bicyclic lactams in high overall yield and excellent purity, under flow through conditions, using a photochemical [2+2] cycloaddition followed by a thermal electrocyclic cascade.
Avacta Group, a clinical stage biopharmaceutical company developing cancer therapies and diagnostics based on its proprietary Affimer and pre|CISION platforms, has made new appointments to its Scientific Advisory Board (SAB),reflecting the progress ofthe Therapeutics Division and Avacta’s transition to a clinical stage company.
Agilent Technologies has signed a worldwide distribution agreement with Visiopharm, enabling Agilent to co-market Visiopharm’s portfolio of CE-IVD marked artificial intelligence (AI)-driven precision pathology software in addition to Agilent’s portfolio of automated pathology staining solutions.
Beukenlaan 137
5616 VD Eindhoven
The Netherlands
+31 85064 55 82
info@clinlabint.com
PanGlobal Media is not responsible for any error or omission that might occur in the electronic display of product or company data.
